We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
BCAAs wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
7 of 13 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
10 of 17 studies with measurable effects showed benefit.
Top outcomes
5-10g per serving
Before fasted training, During long endurance sessions, Between meals
Powder (2:1:1 ratio)
100-200mg daily
With meals, Pre-workout or morning
Pure (-)-Epicatechin extract
24-72 hours post-exercise
During exercise
Ongoing
Immediate
4-8 weeks
2-4 weeks
4-8 weeks
N/A
Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease
European journal of clinical investigation (2023) · Meta analysis · n=2308
According to meta-analyses, long-term (at least 6 months) BCAA supplementation in cirrhotic patients significantly improved event-free survival (p = .008; RR .61 95% CI .42-.88) and tended to improve overall survival (p = .05; RR .58 95% CI .34-1.00).
Branched-chain amino acids for people with hepatic encephalopathy
The Cochrane database of systematic reviews (2017) · Meta analysis · n=827
In a random-effects meta-analysis of mortality, we found no difference between BCAA and controls (risk ratio (RR) 0.88, 95% confidence interval (CI) 0.69 to 1.11; 760 participants; 15 trials; moderate quality of evidence).
Causal Relationship Between Branched-Chain Amino Acids and Hypertension: A Mendelian Randomization Study
Journal of the American Heart Association (2024) · Meta analysis · n=845
As suggested by the meta-analysis results, elevated BCAA levels were associated with a higher risk of hypertension (isoleucine: summary odds ratio, 1.26 [95% CI, 1.08-1.47]; leucine: summary odds ratio, 1.28 [95% CI, 1.07-1.52]; valine: summary odds ratio, 1.32 [95% CI, 1.12-1.57]).
Dietary flavonoid for preventing colorectal neoplasms
The Cochrane database of systematic reviews (2012) · Meta analysis · n=390769
A statistically significant reduced risk of CRC was found with high intake of epicatechin.
Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials
The American journal of clinical nutrition (2012) · Meta analysis · n=1297
Insulin resistance (HOMA-IR: -0.67; 95% CI: -0.98, -0.36) was improved by chocolate or cocoa due to significant reductions in serum insulin.
Impact of flavan-3-ols on blood pressure and endothelial function in diverse populations: a systematic review and meta-analysis of randomized controlled trials
European journal of preventive cardiology (2025) · Meta analysis · n=5205
Flavan-3-ol interventions included epicatechin, epigallocatechin-gallate, cocoa products, tea, grape extract, and apples delivering 586 mg (95% CI 510, 662) total flavan-3-ols.
Evidence limited to resistance training populations. Systematic review found negligible benefits on body composition in athletes. Benefits may be more apparent in caloric deficit or fasted states but data is limited.
Based on meta-analysis showing FMD improvements with flavan-3-ol interventions. Most studies used cocoa products rather than pure epicatechin. Conservative estimate given mixed study designs and populations.
AI-estimated from published studies. Interpret as directional guidance.
BCAAs has a higher evidence score (9/10 vs 8.5/10) and wins in 2 of 3 categories.
Both BCAAs and Epicatechin score equally (65) for build strength & muscle.
No known interactions between BCAAs and Epicatechin have been documented in our database. However, always consult a healthcare provider before combining supplements.